Technologies
Advanced biotechnology platforms for scalable, transfer-ready biopharmaceutical development.
CHO, HEK293 and Pichia pastoris Expression Platforms
Development and optimization of mammalian and microbial expression systems for therapeutic proteins, antibodies, biosimilars, and other recombinant products.
AI-Driven Monoclonal Antibody Engineering
Computationally guided engineering of therapeutic antibodies to support humanization, candidate selection, developability, and biobetter development.
Peptide Oral Delivery and Stable Injectable Formulations
Formulation technologies designed to improve peptide stability, delivery, manufacturability, and therapeutic performance across oral and injectable dosage forms.
Biosensors and Continuous Glucose Monitoring
Technology-development and transfer solutions for biosensor products, with a particular focus on continuous glucose monitoring systems and their associated components.
Pharmaceutical and Biopharmaceutical Manufacturing-Line Design
Conceptual design of manufacturing facilities and production lines aligned with product requirements, process flow, GMP principles, and future scale-up.
Oral Solid Dosage Form Development and Registration
Development of commercially viable oral solid pharmaceutical products supported by formulation design, process development, analytical planning, and registration strategy.